Portfolio company
Finnadvance
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AIM Biotech
This company develops organ-on-a-chip microfluidic platforms and research services for pharmaceutical firms and academic researchers to conduct preclinical human-tissue drug testing.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Tissue Dynamics
This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
ScreenIn3D Limited
This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.
Aclara Biosciences
This company develops microfluidic lab-on-a-chip technology for genomics, drug screening and clinical diagnostics applications for pharmaceutical companies and laboratory researchers.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
